# Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses

> **NCT01703026** · — · COMPLETED · sponsor: **Changi General Hospital** · enrollment: 33 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01703026
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** —
- **Final completion:** 2011-10
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2012-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01703026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01703026, "Contrast Enhanced EUS in the Evaluation of Pancreatic Cancer and Pancreatic Masses". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01703026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*